Most sold healthcare stocks in Q4 2018
See which Healthcare stocks institutional investors trimmed or exited the most in Q4 2018, measured as net reductions in reported share positions from Q3 2018 into Q4 2018. Notable reductions at the top of this list include NOVARTIS AG-SPONSORED ADR (NVS), ELI LILLY & CO (LLY), BAXTER INTERNATIONAL INC (BAX), PACIFIC BIOSCIENCES OF CALIF (PACB). These rankings aggregate SEC 13F filings from all institutional investors in our database.
Explore more:
| Symbol | Name | Net shares | Net value | New | Added | Trimmed | Sold out | Holding now |
|---|---|---|---|---|---|---|---|---|
| NVS | NOVARTIS AG-SPONSORED ADR | -11,660,302 | -$1.02B | 0 | 2 | 7 | 0 | 9 |
| LLY | ELI LILLY & CO | -8,382,670 | -$761.67M | 1 | 1 | 4 | 0 | 6 |
| BAX | BAXTER INTERNATIONAL INC | -8,002,480 | -$942.04M | 0 | 0 | 3 | 0 | 5 |
| PACB | PACIFIC BIOSCIENCES OF CALIF | -7,625,895 | -$40.94M | 1 | 0 | 1 | 0 | 2 |
| TMO | THERMO FISHER SCIENTIFIC INC | -4,741,058 | -$1.22B | 0 | 1 | 8 | 1 | 13 |
| MRK | MERCK & CO. INC. | -3,623,572 | -$190.33M | 1 | 0 | 10 | 0 | 14 |
| DHR | DANAHER CORP | -3,589,191 | -$471.07M | 0 | 1 | 5 | 1 | 9 |
| PFE | PFIZER INC | -3,332,944 | -$154.12M | 0 | 2 | 9 | 1 | 11 |
| CAH | CARDINAL HEALTH INC | -3,253,525 | -$247.34M | 0 | 1 | 5 | 0 | 6 |
| ELAN | ELANCO ANIMAL HEALTH INC | -2,664,173 | -$92.95M | 0 | 0 | 0 | 2 | 0 |
| XRAY | DENTSPLY SIRONA INC | -2,212,731 | -$87.53M | 0 | 1 | 3 | 1 | 5 |
| COR | CENCORA INC | -1,773,213 | -$271.04M | 1 | 0 | 2 | 0 | 3 |
| AZN | ASTRAZENECA PLC-SPONS ADR | -1,651,108 | -$144.06M | 0 | 0 | 1 | 1 | 1 |
| MCK | MCKESSON CORP | -1,253,582 | -$396.76M | 1 | 1 | 3 | 1 | 6 |
| ABBV | ABBVIE INC | -1,166,634 | -$111.71M | 0 | 2 | 4 | 1 | 10 |
| PRGO | Perrigo Company PLC | -1,139,801 | -$139.48M | 0 | 1 | 2 | 1 | 3 |
| CVS | CVS HEALTH CORP | -1,070,287 | -$577.23M | 2 | 3 | 5 | 0 | 10 |
| SNY | SANOFI-ADR | -919,840 | -$117.54M | 0 | 0 | 2 | 1 | 2 |
| AMGN | AMGEN INC | -902,538 | -$248.24M | 0 | 1 | 5 | 0 | 8 |
| VCYT | VERACYTE INC | -806,989 | $4.64M | 0 | 0 | 2 | 0 | 2 |
| PDCO | PATTERSON COS INC | -670,335 | -$23.67M | 0 | 0 | 2 | 0 | 2 |
| SIGA | SIGA TECHNOLOGIES INC | -602,886 | -$4.16M | 0 | 0 | 0 | 1 | 0 |
| JNJ | JOHNSON & JOHNSON | -572,228 | -$206.98M | 0 | 4 | 9 | 0 | 17 |
| HALO | HALOZYME THERAPEUTICS INC | -470,363 | -$17.42M | 0 | 1 | 3 | 0 | 4 |
| CNC | CENTENE CORP | -441,997 | -$104.63M | 0 | 3 | 1 | 1 | 4 |
| GKOS | GLAUKOS CORP | -429,405 | -$29.11M | 0 | 0 | 1 | 0 | 1 |
| RMD | RESMED INC | -414,476 | -$48.41M | 0 | 0 | 1 | 0 | 1 |
| ADAP | ADAPTIMMUNE THERAPEUTICS-ADR | -407,500 | -$10.42M | 0 | 0 | 1 | 0 | 1 |
| VEEV | VEEVA SYSTEMS INC-CLASS A | -388,096 | -$62.66M | 0 | 0 | 1 | 0 | 1 |
| IQV | IQVIA HOLDINGS INC | -381,947 | -$180.76M | 0 | 2 | 1 | 0 | 3 |
| AXGN | AXOGEN INC | -355,900 | -$17.31M | 0 | 0 | 1 | 0 | 1 |
| ISRG | INTUITIVE SURGICAL INC | -355,864 | -$272.36M | 1 | 2 | 2 | 0 | 5 |
| RDNT | RADNET INC | -330,913 | -$13.98M | 0 | 0 | 1 | 0 | 1 |
| IDXX | IDEXX LABORATORIES INC | -307,170 | -$173.59M | 0 | 0 | 3 | 0 | 5 |
| MEDP | MEDPACE HOLDINGS INC | -296,400 | -$21.17M | 0 | 0 | 1 | 0 | 1 |
| EBS | EMERGENT BIOSOLUTIONS INC | -275,300 | -$28.58M | 0 | 0 | 1 | 0 | 1 |
| WAT | WATERS CORP | -272,012 | -$69.29M | 0 | 1 | 3 | 1 | 4 |
| HCA | HCA HEALTHCARE INC | -262,985 | -$73.21M | 0 | 1 | 1 | 2 | 2 |
| MDXG | MIMEDX GROUP INC | -222,973 | -$3.50M | 0 | 0 | 1 | 0 | 1 |
| BCRX | BIOCRYST PHARMACEUTICALS INC | -217,203 | -$1.66M | 0 | 0 | 0 | 1 | 0 |
| EGRX | EAGLE PHARMACEUTICALS INC | -213,822 | -$14.82M | 0 | 0 | 0 | 1 | 0 |
| IART | INTEGRA LIFESCIENCES HOLDING | -209,800 | -$16.90M | 0 | 0 | 1 | 0 | 1 |
| BLUE | BLUEBIRD BIO INC | -203,706 | -$38.96M | 0 | 0 | 1 | 0 | 1 |
| ITCI | INTRA-CELLULAR THERAPIES INC | -203,586 | -$5.86M | 0 | 1 | 0 | 1 | 1 |
| CTMX | CYTOMX THERAPEUTICS INC | -202,700 | -$8.23M | 0 | 0 | 1 | 0 | 1 |
| SGRY | SURGERY PARTNERS INC | -201,800 | -$3.54M | 0 | 0 | 1 | 0 | 1 |
| PTGX | PROTAGONIST THERAPEUTICS INC | -197,400 | -$3.24M | 0 | 0 | 1 | 0 | 1 |
| NTRA | NATERA INC | -192,796 | -$17.95M | 0 | 0 | 1 | 0 | 1 |
| ADMA | ADMA BIOLOGICS INC | -188,300 | -$1.17M | 0 | 0 | 0 | 1 | 0 |
| UHS | UNIVERSAL HEALTH SERVICES-B | -180,418 | -$56.51M | 0 | 1 | 1 | 1 | 2 |
Frequently asked questions about Most sold healthcare stocks in Q4 2018
What are the most sold Healthcare stocks in Q4 2018?
The most sold healthcare stocks in Q4 2018 are those with the largest decrease in reported share counts across institutional investors compared to Q3 2018, based on SEC 13F filings.
Which healthcare stocks did institutional investors trimmed or exited the most in Q4 2018?
Among filers in this sector, net reductions were largest in companies such as NOVARTIS AG-SPONSORED ADR (NVS), ELI LILLY & CO (LLY), BAXTER INTERNATIONAL INC (BAX), based on aggregated 13F data.
How is institutional selling calculated?
Selling is calculated by summing the net decrease in shares reported by institutional investors between two consecutive quarterly 13F snapshots (compared to Q3 2018).
Does this include all institutional owners?
Yes. These rankings aggregate SEC 13F filings from all institutional investors in our database, not only the investors we track individually.
Are these trades real-time?
No. 13F filings are reported quarterly and may be delayed by up to 45 days. The data reflects positions at the end of the reporting period, not real-time trading activity.